Korea FDA Raids Chong Kun Dang On Kickback Allegations

SEOUL - Reflecting the Korean government's bid to crack down on medical kickbacks, Korea FDA investigators, armed with a search and seizure warrant, raided the headquarters and four branches of Chong Kun Dang Pharmaceutical following allegations that the pharma is offering illegal rebates ahead of the launch of the anti-rebate law Nov. 28